Literature DB >> 4032400

Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.

W Pruzanski, P Vadas, E Stefanski, M B Urowitz.   

Abstract

Phospholipase A2 (PLA2) activity was found in the sera and synovial fluids (SF) in rheumatoid arthritis (RA) and osteoarthritis (OA). PLA2 activity in RA SF was 6158 +/- 549 (SEM) U/ml (n = 48) and in RA sera 554 +/- 175 U/ml (normal sera-115 +/- 12 U/ml). In OA SF PLA2 activity was 5069 +/- 542 U/ml (n = 28), and in OA sera 268 +/- 55 U/ml. There was no significant difference between SF PLA2 activity in RA and OA. PLA2 activity in SF did not correlate with muramidase (lysozyme), beta-glucuronidase, total protein or white cell count, which were all significantly higher in RA SF than OA. A positive correlation between PLA2 in SF and matched sera was found in both RA and OA. It may be concluded that significant elevation of extracellular PLA2 occurs in both RA and OA, especially in the SF. The fact that high PLA2 did not correlate with other enzymes such as lysozyme and beta-glucuronidase, which are usually high in RA and low in OA SF, may mean that the handling of PLA2 in the joint space is different from other enzymes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032400

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  52 in total

1.  Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats.

Authors:  W Uhl; H J Schrag; N Schmitter; T J Nevalainen; J Aufenanger; A M Wheatley; M W Büchler
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids.

Authors:  W Pruzanski; K Scott; G Smith; I Rajkovic; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

Review 3.  Synovial fluid phospholipase A2s and inflammation.

Authors:  H Gonzalez-Buritica; M A Khamashita; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

4.  Comparison of group I and II soluble phospholipases A2 activities on phagocytic functions of human polymorphonuclear and mononuclear phagocytes.

Authors:  W Pruzanski; S Saito; E Stefanski; P Vadas
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

5.  Rheumatoid arthritis synovial fluid phospholipase A2 activating protein (PLAP) stimulates human neutrophil degranulation and superoxide ion production.

Authors:  J S Bomalaski; D Baker; N V Resurreccion; M A Clark
Journal:  Agents Actions       Date:  1989-06

6.  The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.

Authors:  P Vadas; W Pruzanski; J Kim; V Fornasier
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

7.  Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.

Authors:  W Pruzanski; F C de Beer; M C de Beer; E Stefanski; P Vadas
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

8.  Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.

Authors:  A N Fonteh; J M Samet; F H Chilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy.

Authors:  K Tanaka; T Kato; K Matsumoto; T Yoshida
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

10.  Elevation of serum phospholipase A2 in patients at an intensive care unit.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; M Tanikawa; Y Nakae; S Kameya
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.